AblaView® Unipolar PFA OCR-guided Feasibility Study - First in Man

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 8, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

February 28, 2025

Conditions
Paroxysmal AF
Interventions
DEVICE

AblaView® Unipolar PFA System

Patients with symptomatic paroxysmal atrial fibrillation will be treated with the AblaView® Unipolar PFA System system to achieve electrical isolation of the pulmonary veins. The AblaView® Unipolar PFA Catheter is a regular PFA irrigated catheter. The tip of the catheter has 7 holes distributed around that deliver at the same time irrigation and near infrared light for the OCR system, which will be processed and interpreted by the Console.

Trial Locations (1)

Unknown

Ezgu Niyat, Tashkent

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Clinical Accelerator

INDUSTRY

lead

Medlumics

INDUSTRY

NCT06700226 - AblaView® Unipolar PFA OCR-guided Feasibility Study - First in Man | Biotech Hunter | Biotech Hunter